March 3, 2021
Mitsubishi Tanabe Pharma has granted Tokyo-based health tech startup DT Axis the rights to the clinical development and marketing of its MTD-810, a cognitive behavioral therapy app for the treatment of depression, the company said on March 1. In a...read more